Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,258 public trials 1,194 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Completed

Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients

NCT01415011

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations
  • Royal Bournemouth Hospital Bournemouth, United Kingdom
  • Beatson West of Scotland Cancer Centre Glasgow, United Kingdom
  • James Paget University Hospital Great Yarmouth, United Kingdom
  • East Kent Hospitals Kent, United Kingdom
View all 15 locations
View Trial Details
Completed

Study of Talazoparib, a PARP Inhibitor, in Patients With Advanced or Recurrent Solid Tumors

NCT01286987

Conditions
Adnexal Diseases, Advanced or Recurrent Solid Tumors, Breast Diseases, +49 more
Locations
  • Scottsdale Healthcare Scottsdale, Arizona, United States
  • Virginia G. Piper Cancer Center Research Pharmacy Scottsdale, Arizona, United States
  • (IRB# 12-000131) Ronald Reagan UCLA Medical Center, Drug Information Center Los Angeles, California, United States
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
View all 15 locations
View Trial Details
Completed

A Study of Paclitaxel/Carboplatin With or Without Olaratumab (IMC-3G3) in Previously Untreated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

NCT00918203

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • ImClone Investigational Site Birmingham, Alabama, United States
  • ImClone Investigational Site Bakersfield, California, United States
  • ImClone Investigational Site Highland, California, United States
  • ImClone Investigational Site Stamford, Connecticut, United States
View all 23 locations
View Trial Details
Completed

Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO

NCT01465802

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • City of Hope Duarte, California, United States
  • St. Jude Heritage Healthcare Fullerton, California, United States
  • UCLA Hematology Oncology Irvine, California, United States
  • UC San Diego Medical Center - La Jolla La Jolla, California, United States
View all 81 locations
View Trial Details
Completed

A Study of Atezolizumab in Participants With Programmed Death-Ligand 1 (PD-L1) Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) [FIR]

NCT01846416

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • HonorHealth Research Institute - Pima Center Scottsdale, Arizona, United States
  • Stanford University/Lucile Packard Children's Hospital Palo Alto, California, United States
  • The Angeles Clinic and Research Institute, Santa Monica Office Santa Monica, California, United States
  • University Of Colorado Aurora, Colorado, United States
View all 31 locations
View Trial Details

Related conditions